Conexeu Sciences Inc. has initiated a warrant exercise inducement program to encourage the early exercise of up to 4,762,780 outstanding common stock purchase warrants. The program, approved on October 21, 2026, offers holders a new "Inducement Warrant" for each existing warrant exercised before the program's deadline.
Key Details
- The Offer: Holders of existing warrants (exercisable at $2.30 per share) who exercise before 4:00 p.m. on April 30, 2027, can purchase one new Inducement Warrant for $0.001.
- Inducement Warrant Terms: Each new warrant allows the purchase of one common share at an exercise price of $3.00 per share for a period of 24 months from its issuance date.
- Share Cap: Due to Nasdaq listing rules, the number of shares issuable from the new Inducement Warrants is capped at 2,563,389 shares until the company obtains shareholder approval. This cap will be applied on a first-to-exercise basis.